Cas:53093-47-3 Proto-pb manufacturer & supplier

Chemical Name:Proto-pb

CAS.NO:53093-47-3

Synonyms:β-D-Glucopyranoside, (3β,22β,25R)-26-(β-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1->2)-O-[O-6-deoxy-α-L-mannopyranosyl-(1->4)-6-deoxy-α-L-m 
annopyranosyl-(1->4)]-;(3β,22R,25R)-26-(β-D-Glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl 6-deoxy-α-L-mannopyranosyl-(1->2)-[6-deoxy-α-L-mannopyranosyl-(1->4)-6-deoxy-α-L-mannopyranosyl-(1->4)]-β-D-gluc
 opyranoside

Molecular Formula:C₅₇H₉₄O₂₆

Molecular Weight:1195.341

HS Code:

Physical and Chemical Properties:

Melting point:N/A

Boiling point:N/A

Density:1.5±0.1 g/cm3

Index of Refraction:1.636

PSA:

Exact Mass:1194.603394

LogP:2.12

Material Safety Information (Applicable for Hazard Chemicals)

RIDADR:

Packing Group:

Contact us for information like β-D-Glucopyranoside, (3β,22β,25R)-26-(β-D-glucopyranosyloxy)-22-hydroxyfurost-5-en-3-yl O-6-deoxy-α-L-mannopyranosyl-(1-&gt chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,opyranoside physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,2)-[6-deoxy-α-L-mannopyranosyl-(1-&gt Use and application,4)]- technical grade,usp/ep/jp grade.

Related News: But Vietnam then partly eased its ban, allowing flights from Hong Kong and Macau to continue, aviation authorities said. Proto-pb manufacturer During analysis of the clinical trial data, the researchers realized that about a third of the participants had low levels of abnormal tau protein, which makes them not very suitable for evaluating the effects of a treatment halting the progression of tau pathology. Proto-pb supplier The active ingredient (AI) is the substance or substances that are biologically active within the drug and is the specific component responsible for the desired effect it has on the individual taking it. Proto-pb vendor Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs. Proto-pb factory Especially tumor drugs with selective targeting characteristics. At present, about 80% of small drug (high-efficiency drug) APIs worldwide are patented drugs.